Update on hemicrania continua
- PMID: 21080113
- PMCID: PMC3021804
- DOI: 10.1007/s11916-010-0156-0
Update on hemicrania continua
Abstract
Hemicrania continua (HC) is a rare primary headache syndrome, characterized by unilateral pain and an absolute response to indometacin. Since the term was first coined in 1984, more than 100 cases have been described worldwide. Most recently, detailed case series that provide more detailed information concerning the sometimes complex clinical presentation of HC have been reported. Functional imaging studies suggest a unique pattern of subcortical involvement in HC: contralateral to the pain posterior hypothalamic region, ipsilateral dorsal pons and ipsilateral ventral midbrain, which, along with the particular effect of indometacin, probably justifies its classification as a unique entity. Increasing the awareness of this primary headache form among clinicians will aid in its diagnosis while further work is being undertaken to characterize the syndrome.
References
-
- Medina JL, Diamond S. Cluster headache variant: spectrum of a new headache syndrome. Archives of Neurology. 1981;38:705–709. - PubMed
-
- Sjaastad O, Spierings EL. Hemicrania continua: another headache absolutely responsive to indomethacin. Cephalalgia. 1984;4:65–70. - PubMed
-
- Boghen D, Desaulniers N. Background vascular headache: relief with indomethacin. Can J Neurol Sci. 1983;10:270–271. - PubMed
-
- Bordini C, Antonaci F, Stovner LJ, Schrader H, Sjaastad O. "Hemicrania continua": a clinical review. Headache. 1991;31:20–26. - PubMed
-
- Newman LC, Lipton RB, Solomon S. Hemicrania continua: ten new cases and a review of the literature. Neurology. 1994;44:2111–2114. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources